Retinal Function in Diabetic Patients Without Retinopathy
NCT ID: NCT00839150
Last Updated: 2011-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
56 participants
OBSERVATIONAL
2005-05-31
2007-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Progression of Retinal Ischemia in Diabetes
NCT05581225
Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With Diabetes
NCT02876744
Diabetic Retinopathy and Subclinical Signs of Disease Transition
NCT03635671
Perifoveal Vascular Network Assessed by OCT-Angiography in Type I Diabetes Mellitus
NCT03422965
Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus
NCT06821399
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Diabetic patients without diabetic retinopathy : No intervention
No interventions assigned to this group
2
Sex and age-matched control subjects : No intervention
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age between 20 and 55
* type 1 or type 2 diabetes mellitus
* diabetes duration of more than 5 years
* no diabetic retinopathy on fundus examination or fundus photographs
* For control subjects :
* sex and age matching with the diabetic patients
* no diabetes, no familial or personal history of elevated blood sugar
Exclusion Criteria
* presence of cataract or history of cataract surgery
* intraocular pressure of more than 21 mmHg
* abnormal score on the Ishihara test
* other ocular disease
* ametropia more than 3 diopters, anisometropia more than 1 diopter, astigmatism more than 1 diopter
* systemic hypertension (defined as systolic blood pressure \> 140 mmHg, diastolic blood pressure \> 90 mmHg)
* treatment with vasoactive drugs
* tobacco consumption of more than 20 cigarettes a day
20 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pascale Massin, MD,Pr;PhD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Lariboisiere
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lecleire-Collet A, Audo I, Aout M, Girmens JF, Sofroni R, Erginay A, Le Gargasson JF, Mohand-Said S, Meas T, Guillausseau PJ, Vicaut E, Paques M, Massin P. Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy. Invest Ophthalmol Vis Sci. 2011 May 2;52(6):2861-7. doi: 10.1167/iovs.10-5960.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P041009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.